elsulfavirine fixed-dose combination
Showing 9976 - 10000 of >10,000
Mesothelioma Trial in Durham, Houston (Durvalumab / tremelimumab, Platinum cisplatin or carboplatin and pemetrexed chemo plus
Not yet recruiting
- Mesothelioma
- Durvalumab / tremelimumab
- Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab
-
Durham, North Carolina
- +1 more
Jul 5, 2023
Meningococcal Infections Trial in Finland (MenACYW conjugate vaccine)
Completed
- Meningococcal Infections
- MenACYW conjugate vaccine
-
Espoo, Finland
- +7 more
Mar 24, 2022
Suicidal Ideation, Suicide Attempt Trial (CAMS Single Session Consultation, Driver Focused Skills Training, Caregiver Skills
Not yet recruiting
- Suicidal Ideation
- Suicide Attempt
- CAMS Single Session Consultation
- +3 more
- (no location specified)
Aug 15, 2023
NSCLC Trial in Worldwide (Nivolumab, Ipilimumab)
Active, not recruiting
- Non-Small Cell Lung Cancer
- Nivolumab
- Ipilimumab
-
Springdale, Arkansas
- +34 more
May 2, 2022
Metastatic Castration-Resistant Prostate Cancer Trial in United States (XmAb20717 + carboplatin + cabazitaxel, XmAb20717 +
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- XmAb20717 + carboplatin + cabazitaxel
- +2 more
-
Duarte, California
- +9 more
May 24, 2022
Advanced Melanoma, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)
Recruiting
- Advanced Melanoma
- +3 more
- Tumor Infiltrating Lymphocyte
-
Shanghai, ChinaShanghai Tenth People's Hospital
Dec 19, 2022
Multiple Myeloma, Relapse Multiple Myeloma Trial in Bethesda, Madison (Descartes-25)
Recruiting
- Multiple Myeloma
- Relapse Multiple Myeloma
-
Shreveport, Louisiana
- +3 more
Nov 4, 2022
Chronic Pain, Opioid Use, Analgesia Trial in Bronx (TapPro)
Enrolling by invitation
- Chronic Pain
- +2 more
- TapPro
-
Bronx, New YorkMontefiore Medical Center
May 4, 2022
Gastric Adenocarcinoma, Metastatic Adenocarcinoma of the Gastroesophageal Junction Trial in Germany (Ramucirumab, TAS 102)
Active, not recruiting
- Gastric Adenocarcinoma
- Metastatic Adenocarcinoma of the Gastroesophageal Junction
- Ramucirumab
- TAS 102
-
Frankfurt, Germany
- +4 more
Mar 2, 2022
Recurrent DLBCL Activated B-Cell Type, Recurrent DLBCL Germinal Center B-Cell Type, Recurrent High Grade B-Cell Lymphoma With
Recruiting
- Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
- +8 more
- Biospecimen Collection
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Mar 8, 2023
Chronic Rhinosinusitis (Diagnosis) Trial in Darlinghurst (Betamethasone Dipropionate Nasal Cream 0.0644%, Pre-filled syringe and
Recruiting
- Chronic Rhinosinusitis (Diagnosis)
- Betamethasone Dipropionate Nasal Cream 0.0644%
- Pre-filled syringe and applicator device
-
Darlinghurst, New South Wales, AustraliaSydney Ear Nose and Throat Clinic Pty Ltd
Sep 19, 2022
Tumor Malignant Trial in Worldwide (SAR245408, SAR245409)
Completed
- Neoplasm Malignant
-
Birmingham, Alabama
- +20 more
Mar 30, 2022
Total Shoulder Athroplasty Trial in New York (Tranexamic Acid Injection)
Recruiting
- Total Shoulder Athroplasty
- Tranexamic Acid Injection
-
New York, New YorkNYU Langone Health
Jul 7, 2022
Chemo-induced Peripheral Neuropathy Trial (N Acetylcysteine A, N Acetylcysteine B)
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- N Acetylcysteine A
- N Acetylcysteine B
- (no location specified)
Sep 12, 2022
Chronic Kidney Disease Trial (HRS-1780 table or )
Not yet recruiting
- Chronic Kidney Disease
- HRS-1780 table or placebo
- (no location specified)
Dec 5, 2022
Herpes Zoster Trial in Bengbu (PEGIFNa1b, Placebo)
Completed
- Herpes Zoster
- PEGIFNα1b
- Placebo
-
Bengbu, Anhui, ChinaThe first affiliated hospital of bengbu medical college
Nov 28, 2022
Urinary Bladder, Overactive, Urodynamics, Effect of Drug Trial in Taipei (Intradetrusor Botox® (onabotulinumtoxinA) injection,
Recruiting
- Urinary Bladder, Overactive
- +2 more
- Intradetrusor Botox® (onabotulinumtoxinA) injection
- Combine Mirabegron and Solifenacin.
-
Taipei, TaiwanMackay Memorial Hospital
Jul 29, 2023
Spinal Cord Injury Trial in Chicago (drug, other, behavioral)
Recruiting
- Spinal Cord Injury
- Dalfampridine
- +3 more
-
Chicago, IllinoisShirley Ryan Abilitylab
Jul 6, 2022
Postoperative Retention of Urine Trial in Evanston (Tamsulosin, Placebo)
Not yet recruiting
- Postoperative Retention of Urine
- Tamsulosin
- Placebo
-
Evanston, IllinoisNorthShore University Health System
Mar 6, 2023
Parkinson's Disease Trial in Peoria, Bingham Farms (Sinemet 25-100 Oral Tablet, XP21279, Carbidopa Pill)
Completed
- Parkinson's Disease
- Sinemet 25-100 Oral Tablet
- +2 more
-
Peoria, Arizona
- +1 more
Apr 30, 2021
Healthy Trial in Randwick (CSL324, Placebo)
Completed
- Healthy
- CSL324
- Placebo
-
Randwick, AustraliaScientia Clinical Research Ltd
Oct 3, 2022
NSCLC NSCLC Trial in Worldwide (Durvalumab, Placebo for Olaparib, Olaparib)
Active, not recruiting
- Non-small Cell Lung Cancer NSCLC
- Durvalumab
- +7 more
-
Bonita Springs, Florida
- +67 more
Nov 15, 2022